Journal articles on the topic 'Chemotherapy (CT)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Chemotherapy (CT).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Tomaro, Maria, Paula Silverman, Wendy Rowehl Miano, Amy Wakeling, and Kathleen Gonzalez. "Chemotherapy safety initiative." Journal of Clinical Oncology 31, no. 31_suppl (November 1, 2013): 226. http://dx.doi.org/10.1200/jco.2013.31.31_suppl.226.
Full textRobinson, S. I., J. Murray, and R. R. McWilliams. "Celiac disease and chemotherapy." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 19561. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.19561.
Full textRehan, Fareed A., Corinne Brillant, Holger Schulz, Ina Knauel, Julia Bohlius, Lena Specht, and Andreas Engert. "Chemotherapy Alone Versus Chemotherapy Plus Radiotherapy for Early Stage Hodgkin Lymphoma." Blood 110, no. 11 (November 16, 2007): 2320. http://dx.doi.org/10.1182/blood.v110.11.2320.2320.
Full textDebled, M., A. Trainaud, M. Durand, A. Floquet, V. Brouste, and L. Mauriac. "Administration of further chemotherapy (CT) after capecitabine as first-line chemotherapy (CT) for metastatic breast cancer (MBC)." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 1095. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.1095.
Full textZhu, Yunshu, Sheng Yang, Shengyu Zhou, Jianliang Yang, Yan Qin, Lin Gui, Yuankai Shi, and Xiaohui He. "Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma." Therapeutic Advances in Medical Oncology 12 (January 2020): 175883592095373. http://dx.doi.org/10.1177/1758835920953738.
Full textAli, Maria, M. Christine Cripps, Katelyn Balchin, Jennifer Spencer, and Paul Wheatley-Price. "Palliative inpatient chemotherapy: Clinical benefit or harm?" Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e19527-e19527. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e19527.
Full textLandre, Thierry, Kader Chouahnia, Gaëtan Des Guetz, Boris Duchemann, Jean-Baptiste Assié, and Christos Chouaïd. "First-line immune-checkpoint inhibitor plus chemotherapy versus chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis." Therapeutic Advances in Medical Oncology 12 (January 2020): 175883592097713. http://dx.doi.org/10.1177/1758835920977137.
Full textLampe, H., A. Horwich, A. Norman, J. Nicholls, and D. P. Dearnaley. "Fertility after chemotherapy for testicular germ cell cancers." Journal of Clinical Oncology 15, no. 1 (January 1997): 239–45. http://dx.doi.org/10.1200/jco.1997.15.1.239.
Full textRefaie, Huda, Mohamed Sarhan, and Ashraf Hafez. "Role of CT in Assessment of Unresectable Wilms' Tumor Response after Preoperative Chemotherapy in Pediatrics." Scientific World JOURNAL 8 (2008): 661–69. http://dx.doi.org/10.1100/tsw.2008.96.
Full textYoon, Choon Sik, Myung Jun Kim, Mi Hae Kim, and Ki Keun Oh. "Wilms' tumor:Changes of CT findings after chemotherapy." Journal of the Korean Radiological Society 29, no. 6 (1993): 1331. http://dx.doi.org/10.3348/jkrs.1993.29.6.1331.
Full textAleixo, Gabriel, Stephanie A. Valente, Wei Wei, Po-Hao Chen, and Halle C. F. Moore. "CT scan versus bioelectrical impedance spectrometry sarcopenia assessment to predict chemotherapy toxicity in early breast cancer." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 12078. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.12078.
Full textLiu, G., E. Franssen, M. I. Fitch, and E. Warner. "Patient preferences for oral versus intravenous palliative chemotherapy." Journal of Clinical Oncology 15, no. 1 (January 1997): 110–15. http://dx.doi.org/10.1200/jco.1997.15.1.110.
Full textChen, Zhanhong, Xiaojia Wang, Jian Huang, Yabing Zheng, Xiying Shao, Wenming Cao, Junqing Chen, et al. "Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 1072. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.1072.
Full textChirivella, I., B. Bermejo, A. Insa, A. Perez-Fidalgo, A. Magro, S. Rosello, E. Garcia-Garre, P. Martin, A. Bosch, and A. Lluch. "Impact of chemotherapy dose-related factors on survival in breast cancer patients treated with adjuvant anthracycline-based chemotherapy." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 668. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.668.
Full textDeniz, Gulhan Ipek, Ayten Can, and Sualp Tansan. "Chemotherapy and radiofrequency hyperthermia in advanced ovarian cancer." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): e17550-e17550. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e17550.
Full textZander, A. R., N. Kroeger, C. Schmoor, W. Krueger, V. Moebus, N. Frickhofen, B. Metzner, et al. "Randomized trial of high-dose chemotherapy with autologous haematopoietic stem cell support vs. standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: Overall survival after 6 years of follow up." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 672. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.672.
Full textBoige, Valerie, Jean-Pierre Pignon, Mathilde Wagner, Eric Dupont Bierre, Samuel Le Sourd, Franck Audemar, Ayhan Ulusakarya, et al. "PRODIGE 53-UCGI 30 (SULTAN): A randomized phase II study comparing treatment intensification with hepatic arterial infusion chemotherapy plus systemic chemotherapy to systemic chemotherapy alone in patients with liver-only colorectal metastases considered still non resectable after at least two months of systemic induction chemotherapy." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): TPS3619. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.tps3619.
Full textYoh, Kiyotaka, Yasushi Goto, Yoichi Naito, Kazuma Kishi, Yasuo Ohashi, and Hideo Kunitoh. "Prospective observational cohort study of second-line chemotherapy administration after first-line platinum-based chemotherapy for patients with advanced NSCLC in Japan (SAPPHIRE study)." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 8058. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.8058.
Full textBergmann, L., A. Klima, A. Zoubek, S. Szepesi, C. v. Ilberg, and P. S. Mitrou. "Chemotherapy and radiotherapy (CT+RT) vs. chemotherapy alone (CT) in the treatment of advanced head and neck cancer (HNC)." Journal of Cancer Research and Clinical Oncology 111, S1 (February 1986): S123. http://dx.doi.org/10.1007/bf02580260.
Full textCarey, R. W., A. D. Hilgenberg, E. W. Wilkins, N. C. Choi, D. J. Mathisen, and H. Grillo. "Preoperative chemotherapy followed by surgery with possible postoperative radiotherapy in squamous cell carcinoma of the esophagus: evaluation of the chemotherapy component." Journal of Clinical Oncology 4, no. 5 (May 1986): 697–701. http://dx.doi.org/10.1200/jco.1986.4.5.697.
Full textKalinka-Warzocha, Ewa, Javier Gallego Plazas, Laurent Mineur, Tomas Salek, Alain Hendlisz, Kate Bendall, Florian D. Vogl, and Rodolfo Passalacqua. "Chemotherapy (CT) treatment patterns and neutropenia management in gastric cancer patients (pts) receiving myelosuppressive chemotherapy in Europe." Journal of Clinical Oncology 31, no. 4_suppl (February 1, 2013): 128. http://dx.doi.org/10.1200/jco.2013.31.4_suppl.128.
Full textSamalin, Emmanuelle, Tien Tuan Nguyen, Simon Thezenas, Fabienne Portales, Thibault Mazard, Sophie Gourgou, Eric Assenat, and Marc Ychou. "Chemotherapy efficacy in metastatic colorectal cancer (mCRC) patients treated with adjuvant or first-line FOLFOX-based chemotherapy." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e15048-e15048. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e15048.
Full textWislez, Marie, Thibault Vieira, Mony Ung, Martine Antoine, Isabelle Monnet, Pierre Bonnette, Aurelie Cazes, et al. "Are sarcomatoid lung cancers resistant tumors to conventional chemotherapy?" Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e19036-e19036. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e19036.
Full textRimassa, L., A. Chiti, C. Carnaghi, R. Doci, M. Zuradelli, G. Abbadessa, F. R. Lutman, M. C. Tronconi, T. Pressiani, and A. Santoro. "18F-FDG PET (PET) does not improve CT scan (CT) accuracy in the evaluation of colorectal cancer liver metastases after chemotherapy." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 13530. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.13530.
Full textBokemeyer, C., C. Kollmannsberger, C. Meisner, A. Harstrick, J. Beyer, B. Metzner, J. T. Hartmann, et al. "First-Line High-Dose Chemotherapy Compared With Standard-Dose PEB/VIP Chemotherapy in Patients With Advanced Germ Cell Tumors: A Multivariate and Matched-Pair Analysis." Journal of Clinical Oncology 17, no. 11 (November 1999): 3450–56. http://dx.doi.org/10.1200/jco.1999.17.11.3450.
Full textCheung, Yin Ting, Maung Shwe Ham Guo, Wai Keung Chui, Rebecca Alexandra Dent, Yoon Sim Yap, Soo Kien Lo, Raymond C. H. Ng, and Alexandre Chan. "Effect of chemotherapy and psychosocial distress parameters on perceived cognitive disturbances in Asian breast cancer patients." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 9041. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9041.
Full textCohen, Bar, Nurith Hiller, Auryan Szalat, and Vladimir Vainstein. "OPPORTUNISTIC EVALUATION OF BONE MINERAL DENSITY BY PET-CT IN HODGKIN LYMPHOMA PATIENTS." Endocrine Practice 25, no. 9 (September 2019): 869–76. http://dx.doi.org/10.4158/ep-2019-0122.
Full textJi, Xiang, Qiaoyun Yang, Hui Qin, Jie Zhou, and Wenming Liu. "Tumor blood supply may predict neoadjuvant chemotherapy response and survival in patients with gastric cancer." Journal of International Medical Research 47, no. 6 (May 1, 2019): 2524–32. http://dx.doi.org/10.1177/0300060519845491.
Full textLai, Pamela, Shelly Sud, Tinghua Zhang, Timothy R. Asmis, and Paul Wheatley-Price. "Palliative chemotherapy in advanced colorectal cancer patients age 80 or older." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e14598-e14598. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e14598.
Full textBeyhan Sagmen, Seda, Sevda Comert, Esra Turan Erkek, Aysun Küçüköz Uzun, Coşkun Doğan, Guven Yılmaz, Nesrin Kıral, Ali Fidan, Çağla Yılmaz Haksal, and Elif Torun Parmaksız. "Can We Predict Bleomycin Toxicity with PET-CT?" Acta Haematologica 142, no. 3 (2019): 171–75. http://dx.doi.org/10.1159/000502374.
Full textFenaux, Pierre, Claude Chastang, Sylvie Chevret, Miguel Sanz, Hervé Dombret, Eric Archimbaud, Martin Fey, et al. "A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia." Blood 94, no. 4 (August 15, 1999): 1192–200. http://dx.doi.org/10.1182/blood.v94.4.1192.
Full textFenaux, Pierre, Claude Chastang, Sylvie Chevret, Miguel Sanz, Hervé Dombret, Eric Archimbaud, Martin Fey, et al. "A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia." Blood 94, no. 4 (August 15, 1999): 1192–200. http://dx.doi.org/10.1182/blood.v94.4.1192.416k07_1192_1200.
Full textStomper, PC, MS Jochelson, EL Friedman, MB Garnick, and JP Richie. "CT evaluation of advanced seminoma treated with chemotherapy." American Journal of Roentgenology 146, no. 4 (April 1986): 745–48. http://dx.doi.org/10.2214/ajr.146.4.745.
Full textAita, M., O. Belvedere, F. De Pauli, L. Deroma, L. Gurrieri, J. Menis, V. Merlo, F. Puglisi, L. Zanier, and G. Fasola. "Information technology (IT) and chemotherapy (CT) prescribing errors." Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 6080. http://dx.doi.org/10.1200/jco.2010.28.15_suppl.6080.
Full textGörich, J., N. Rilinger, R. Sokiranski, J. Vogel, M. Wikström, S. Krämer, E. Merkle, A. Rieber, and H. J. Brambs. "CT-guided intraarterial chemotherapy in locally advanced tumors." Radiology 199, no. 2 (May 1996): 567–70. http://dx.doi.org/10.1148/radiology.199.2.8668814.
Full textNg, Y. Y., M. A. Hall-Craggs, C. Dicks-Mireaux, and J. Pritchard. "Wilms' tumour: Pre- and post-chemotherapy CT appearances." Clinical Radiology 43, no. 4 (April 1991): 255–59. http://dx.doi.org/10.1016/s0009-9260(05)80250-8.
Full textAzmy, Amir. "Wilms' tumours: Pre- and post-chemotherapy CT appearances." Journal of Pediatric Surgery 26, no. 11 (November 1991): 1354–55. http://dx.doi.org/10.1016/0022-3468(91)90654-c.
Full textVernuccio, Federica, Marco Dioguardi Burgio, Filippo Barbiera, Silvestro Cusmà, Giuseppe Badalamenti, Massimo Midiri, Valérie Vilgrain, and Giuseppe Brancatelli. "CT and MR imaging of chemotherapy-induced hepatopathy." Abdominal Radiology 44, no. 10 (August 21, 2019): 3312–24. http://dx.doi.org/10.1007/s00261-019-02193-y.
Full textRübe, Ch, M. Thomas, M. Semik, and D. Riesenbeck. "Chemotherapy (CT) and twice daily radio-chemotherapy (HA RT/CT) versus chemotherapy (CT) alone before surgery in stage III non small cell lung cancer (NSCLC): analysis of toxicity of a randomized trial." European Journal of Cancer 35 (September 1999): S249. http://dx.doi.org/10.1016/s0959-8049(99)81408-7.
Full textCho, May Thet, Jonathan Kessler, John Park, Gagandeep Singh, Yi-Jen Chen, Philip HG Ituarte, and Marwan Fakih. "A single institute retrospective trial of concurrent chemotherapy with SIR-Sphere versus SIR-Sphere alone in patients with chemotherapy-resistant colorectal cancer liver metastases." Journal of Clinical Oncology 34, no. 4_suppl (February 1, 2016): 770. http://dx.doi.org/10.1200/jco.2016.34.4_suppl.770.
Full textde Geus, Susanna W. L., Sameer Hirji, Sing Chau Ng, Teviah E. Sachs, and Jennifer F. Tseng. "First-line chemotherapy versus chemoradiation for resectable distal esophageal adenocarcinoma." Journal of Clinical Oncology 38, no. 4_suppl (February 1, 2020): 331. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.331.
Full textErmacora, P., P. Driol, S. Russo, C. Andreetta, F. E. Pisa, B. Alessi, A. M. Minisini, M. Mansutti, G. Fasola, and F. Puglisi. "Predictors of tumor shrinkage after anthracycline-based preoperative chemotherapy." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e11531-e11531. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e11531.
Full textMoser, Justin, Benjamin Solomon, Christopher Duane Nevala-Plagemann, Glynn Weldon Gilcrease, Jonathan R. Whisenant, and Ignacio Garrido-Laguna. "Survival of patients with metastatic HER2 positive gastroesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on frontline chemotherapy plus trastuzumab." Journal of Clinical Oncology 37, no. 4_suppl (February 1, 2019): 69. http://dx.doi.org/10.1200/jco.2019.37.4_suppl.69.
Full textDerks, Jules, Noémie Leblay, Robert Jan van Suylen, Erik Thunnissen, Michael den Bakker, Harry J. M. Groen, Egbert F. Smit, et al. "Genetic subtypes of large cell neuroendocrine carcinoma (LCNEC) to predict response to chemotherapy." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 9061. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.9061.
Full textGalsky, Matt D., Andrea Necchi, Srikala S. Sridhar, Osamu Ogawa, Natasha Angra, Stephan Hois, Feng Xiao, Erik Goluboff, and Joaquim Bellmunt. "A phase III, randomized, open-label, multicenter, global study of first-line durvalumab plus standard of care (SoC) chemotherapy and durvalumab plus tremelimumab, and SoC chemotherapy versus SoC chemotherapy alone in unresectable locally advanced or metastatic urothelial cancer (NILE)." Journal of Clinical Oncology 39, no. 6_suppl (February 20, 2021): TPS504. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.tps504.
Full textSuh, Byoung Jo. "A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis Treated with Preoperative FOLFOX Chemotherapy Followed by Radical Subtotal Gastrectomy and D2 Lymph Node Dissection." Case Reports in Oncology 10, no. 1 (February 15, 2017): 182–91. http://dx.doi.org/10.1159/000457791.
Full textGlynne-Jones, Rob, and Peter Hoskin. "Neoadjuvant Cisplatin Chemotherapy Before Chemoradiation: A Flawed Paradigm?" Journal of Clinical Oncology 25, no. 33 (November 20, 2007): 5281–86. http://dx.doi.org/10.1200/jco.2007.12.3133.
Full textLiu, Feng, Shengnan Fu, Yanzhu Chen, Ouying Yan, Lili He, Cuihong Jiang, Xiangwei Wu, Yaqian Han, and Hui Wang. "A randomized phase II trial of diffusion-weighted MR imaging-guided radiotherapy plus chemotherapy versus standard chemoradiotherapy in locoregional advanced nasopharyngeal carcinoma." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 6018. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.6018.
Full textMontravers, Françoise, Marc Tassart, Sophie Périé, Khaldoun Kerrou, Jean-NOËL Talbot, Bruno Angelard, and Jean Lacau St Guily. "Fluorodeoxyglucose Imaging Using a Coincidence Gamma Camera to Detect Head and Neck Squamous Cell Carcinoma and Response to Chemotherapy." Annals of Otology, Rhinology & Laryngology 111, no. 9 (September 2002): 763–71. http://dx.doi.org/10.1177/000348940211100901.
Full textCullen, M. H., L. J. Billingham, C. M. Woodroffe, A. D. Chetiyawardana, N. H. Gower, R. Joshi, D. R. Ferry, et al. "Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life." Journal of Clinical Oncology 17, no. 10 (October 1999): 3188–94. http://dx.doi.org/10.1200/jco.1999.17.10.3188.
Full text